Pruzanski Mark
Insider CIK 1559569 · ICPT See Remarks, Director · EQ Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| EQ Equillium, Inc. | A Award deriv | 2026-05-28 | 2026-05-29 | 70,000 | — | $0 | 70,000 | SEC↗ |
| EQ Equillium, Inc. | A Award deriv | 2025-05-21 | 2025-05-23 | 20,000 | — | $0 | 20,000 | SEC↗ |
| EQ Equillium, Inc. | D To issuer deriv | 2025-02-14 | 2025-02-19 | 24,000 | — | $0 | 0 | SEC↗ |
| EQ Equillium, Inc. | A Award deriv | 2025-02-14 | 2025-02-19 | 12,000 | — | $0 | 12,000 | SEC↗ |
| EQ Equillium, Inc. | A Award deriv | 2025-02-14 | 2025-02-19 | 20,000 | — | $0 | 20,000 | SEC↗ |
| EQ Equillium, Inc. | D To issuer deriv | 2025-02-14 | 2025-02-19 | 20,770 | — | $0 | 0 | SEC↗ |
| EQ Equillium, Inc. | A Award deriv | 2025-02-14 | 2025-02-19 | 20,770 | — | $0 | 20,770 | SEC↗ |
| EQ Equillium, Inc. | D To issuer deriv | 2025-02-14 | 2025-02-19 | 20,000 | — | $0 | 0 | SEC↗ |
| EQ Equillium, Inc. | A Award deriv | 2025-02-14 | 2025-02-19 | 24,000 | — | $0 | 24,000 | SEC↗ |
| EQ Equillium, Inc. | D To issuer deriv | 2025-02-14 | 2025-02-19 | 12,000 | — | $0 | 0 | SEC↗ |
| EQ Equillium, Inc. | A Award deriv | 2024-05-22 | 2024-05-23 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | D To issuer deriv | 2023-11-08 | 2023-11-13 | 889 | — | $0 | 0 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | D To issuer deriv | 2023-11-08 | 2023-11-13 | 45,293 | — | $0 | 0 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | D To issuer deriv | 2023-11-08 | 2023-11-13 | 207 | — | $0 | 0 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | D To issuer deriv | 2023-11-08 | 2023-11-13 | 38,793 | — | $0 | 0 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | D To issuer deriv | 2023-11-08 | 2023-11-13 | 1,207 | — | $0 | 0 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | D To issuer deriv | 2023-11-08 | 2023-11-13 | 29,865 | — | $0 | 0 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | D To issuer deriv | 2023-11-08 | 2023-11-13 | 635 | — | $0 | 0 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | D To issuer deriv | 2023-11-08 | 2023-11-13 | 31,506 | — | $0 | 0 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | D To issuer deriv | 2023-11-08 | 2023-11-13 | 12,811 | — | $0 | 0 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | D To issuer deriv | 2023-11-08 | 2023-11-13 | 17,700 | — | $0 | 0 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | D To issuer deriv | 2023-11-08 | 2023-11-13 | 1,044 | — | $0 | 0 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | D To issuer deriv | 2023-11-08 | 2023-11-13 | 332 | — | $0 | 0 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | D To issuer deriv | 2023-11-08 | 2023-11-13 | 5,401 | — | $0 | 0 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | U Tender | 2023-11-08 | 2023-11-13 | 618,894 | $19.00 | $11.76M | 0 | SEC↗ |
| EQ Equillium, Inc. | A Award deriv | 2023-05-22 | 2023-05-23 | 20,000 | — | $0 | 20,000 | SEC↗ |
| EQ Equillium, Inc. | A Award deriv | 2022-05-24 | 2022-05-25 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | F Tax w/h | 2021-11-30 | 2021-12-02 | 3,817 | $17.21 | $65.7K | 618,894 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | A Award | 2021-11-30 | 2021-12-02 | 6,138 | $17.21 | $105.6K | 622,711 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | F Tax w/h | 2021-10-29 | 2021-11-02 | 3,817 | $16.86 | $64.4K | 616,573 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | A Award | 2021-10-29 | 2021-11-02 | 6,138 | $16.86 | $103.5K | 620,390 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | F Tax w/h | 2021-09-30 | 2021-10-04 | 3,816 | $14.85 | $56.7K | 614,252 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | A Award | 2021-09-30 | 2021-10-04 | 6,136 | $14.85 | $91.1K | 618,068 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | A Award | 2021-08-31 | 2021-09-01 | 6,138 | $14.91 | $91.5K | 615,749 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | F Tax w/h | 2021-08-31 | 2021-09-01 | 3,817 | $14.91 | $56.9K | 611,932 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | F Tax w/h | 2021-07-30 | 2021-08-02 | 3,817 | $17.28 | $66.0K | 609,611 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | A Award | 2021-07-30 | 2021-08-02 | 6,138 | $17.28 | $106.1K | 613,428 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | F Tax w/h | 2021-06-30 | 2021-07-01 | 3,816 | $19.97 | $76.2K | 607,290 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | A Award | 2021-06-30 | 2021-07-01 | 6,136 | $19.97 | $122.5K | 611,106 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | A Award | 2021-05-28 | 2021-06-02 | 6,138 | $16.63 | $102.1K | 608,787 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | F Tax w/h | 2021-05-28 | 2021-06-02 | 3,817 | $16.63 | $63.5K | 604,970 | SEC↗ |
| EQ Equillium, Inc. | A Award deriv | 2021-05-26 | 2021-05-28 | 20,770 | — | $0 | 20,770 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | A Award | 2021-04-30 | 2021-05-04 | 6,138 | $19.78 | $121.4K | 506,466 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | F Tax w/h | 2021-04-30 | 2021-05-04 | 3,817 | $19.78 | $75.5K | 502,649 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | F Tax w/h | 2021-03-31 | 2021-04-01 | 3,658 | $23.08 | $84.4K | 500,328 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | A Award | 2021-03-31 | 2021-04-01 | 6,136 | $23.08 | $141.6K | 503,986 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | F Tax w/h | 2021-02-26 | 2021-03-02 | 2,741 | $21.66 | $59.4K | 497,850 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | A Award | 2021-02-26 | 2021-03-02 | 6,138 | $21.66 | $132.9K | 500,591 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | A Award | 2021-01-29 | 2021-02-02 | 6,138 | $35.24 | $216.3K | 497,194 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | F Tax w/h | 2021-01-29 | 2021-02-02 | 2,741 | $35.24 | $96.6K | 494,453 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | F Tax w/h | 2021-01-01 | 2021-01-05 | 632 | $24.70 | $15.6K | 491,056 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | A Award | 2020-12-31 | 2021-01-05 | 41,236 | $24.70 | $1.02M | 516,753 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | F Tax w/h | 2020-12-31 | 2021-01-05 | 25,065 | $24.70 | $619.1K | 491,688 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | F Tax w/h | 2020-10-01 | 2020-10-05 | 772 | $42.08 | $32.5K | 475,517 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | F Tax w/h | 2020-07-01 | 2020-07-06 | 772 | $46.52 | $35.9K | 476,289 | SEC↗ |
| EQ Equillium, Inc. | A Award deriv | 2020-05-19 | 2020-05-21 | 24,000 | — | $0 | 24,000 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | F Tax w/h | 2020-04-01 | 2020-04-03 | 568 | $58.40 | $33.2K | 477,061 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | A Award deriv | 2020-01-23 | 2020-01-27 | 17,700 | — | $0 | 17,700 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | A Award | 2020-01-23 | 2020-01-27 | 10,800 | — | $0 | 477,629 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | F Tax w/h | 2020-01-01 | 2020-01-03 | 1,166 | $123.92 | $144.5K | 466,829 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | M Exercise deriv | 2019-12-31 | 2020-01-03 | 100 | — | $0 | 30,084 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | F Tax w/h | 2019-12-31 | 2020-01-03 | 1,131 | $123.92 | $140.2K | 467,995 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | S Sale | 2019-12-31 | 2020-01-03 | 100 | $125.00 | $12.5K | 469,126 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | M Exercise | 2019-12-31 | 2020-01-03 | 100 | $21.50 | $2.1K | 469,226 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | M Exercise deriv | 2019-12-26 | 2019-12-30 | 417 | — | $0 | 30,184 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | M Exercise | 2019-12-26 | 2019-12-30 | 417 | $21.50 | $9.0K | 469,543 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | S Sale | 2019-12-26 | 2019-12-30 | 417 | $125.00 | $52.1K | 469,126 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | M Exercise deriv | 2019-11-26 | 2019-11-27 | 19,880 | — | $0 | 0 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | M Exercise deriv | 2019-11-26 | 2019-11-27 | 15,557 | — | $0 | 30,601 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | S Sale | 2019-11-26 | 2019-11-27 | 35,437 | $100.00 | $3.54M | 469,126 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | M Exercise | 2019-11-26 | 2019-11-27 | 19,880 | $8.67 | $172.4K | 489,006 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | M Exercise | 2019-11-26 | 2019-11-27 | 15,557 | $21.50 | $334.5K | 504,563 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | M Exercise deriv | 2019-11-25 | 2019-11-27 | 14,524 | — | $0 | 19,880 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | M Exercise deriv | 2019-11-25 | 2019-11-27 | 39 | — | $0 | 0 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | S Sale | 2019-11-25 | 2019-11-27 | 14,563 | $100.00 | $1.46M | 469,126 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | M Exercise | 2019-11-25 | 2019-11-27 | 14,524 | $8.67 | $125.9K | 483,689 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | M Exercise | 2019-11-25 | 2019-11-27 | 39 | $8.67 | $338 | 469,165 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | F Tax w/h | 2019-10-01 | 2019-10-03 | 1,547 | $65.87 | $101.9K | 469,126 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | F Tax w/h | 2019-07-01 | 2019-07-03 | 1,548 | $79.17 | $122.6K | 470,673 | SEC↗ |
| EQ Equillium, Inc. | A Award deriv | 2019-06-11 | 2019-06-13 | 12,000 | — | $0 | 12,000 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | F Tax w/h | 2019-04-01 | 2019-04-03 | 1,547 | $111.50 | $172.5K | 472,221 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | A Award deriv | 2019-01-16 | 2019-01-18 | 13,700 | — | $0 | 13,700 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | A Award | 2019-01-16 | 2019-01-18 | 8,500 | — | $0 | 573,768 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | F Tax w/h | 2019-01-01 | 2019-01-03 | 1,537 | $100.79 | $154.9K | 565,268 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | M Exercise deriv | 2018-11-16 | 2018-11-16 | 27,606 | — | $0 | 39 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | M Exercise | 2018-11-16 | 2018-11-16 | 27,606 | $8.67 | $239.3K | 594,411 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | S Sale | 2018-11-16 | 2018-11-16 | 7,839 | $102.61 | $804.4K | 568,793 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | S Sale | 2018-11-16 | 2018-11-16 | 7,949 | $101.48 | $806.7K | 576,632 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | S Sale | 2018-11-16 | 2018-11-16 | 9,830 | $100.38 | $986.7K | 584,581 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | S Sale | 2018-11-16 | 2018-11-16 | 1,988 | $103.29 | $205.3K | 566,805 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | M Exercise deriv | 2018-11-15 | 2018-11-16 | 22,394 | — | $0 | 27,645 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | S Sale | 2018-11-15 | 2018-11-16 | 3,521 | $101.13 | $356.1K | 566,805 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | S Sale | 2018-11-15 | 2018-11-16 | 18,873 | $100.38 | $1.89M | 570,326 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | M Exercise | 2018-11-15 | 2018-11-16 | 22,394 | $8.67 | $194.2K | 589,199 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | F Tax w/h | 2018-10-01 | 2018-10-03 | 2,049 | $126.46 | $259.1K | 566,805 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | F Tax w/h | 2018-07-01 | 2018-10-03 | 2,051 | $83.91 | $172.1K | 566,805 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | P Buy | 2018-04-09 | 2018-04-09 | 7,812 | $64.00 | $500.0K | 576,564 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | F Tax w/h | 2018-04-01 | 2018-10-03 | 2,050 | $61.52 | $126.1K | 566,805 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | A Award deriv | 2018-02-05 | 2018-02-22 | 45,500 | — | $0 | 45,500 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | F Tax w/h | 2018-01-01 | 2018-10-03 | 3,609 | $58.42 | $210.8K | 566,805 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2017-10-02 | 2017-10-04 | 1,532 | $58.87 | $90.2K | 568,752 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2017-07-03 | 2017-07-05 | 1,434 | $121.78 | $174.6K | 570,284 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2017-06-26 | 2017-06-28 | 40,000 | — | $0 | 50,039 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2017-06-26 | 2017-06-28 | 2,043 | $133.07 | $271.9K | 571,718 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2017-06-26 | 2017-06-28 | 5,485 | $132.54 | $727.0K | 573,761 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2017-06-26 | 2017-06-28 | 5,893 | $131.18 | $773.0K | 579,246 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2017-06-26 | 2017-06-28 | 18,763 | $130.46 | $2.45M | 585,139 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2017-06-26 | 2017-06-28 | 7,816 | $129.49 | $1.01M | 603,902 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2017-06-26 | 2017-06-28 | 40,000 | $8.67 | $346.8K | 611,718 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2017-04-03 | 2017-04-05 | 1 | $115.00 | $137 | 571,718 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | A Award deriv | 2017-02-01 | 2017-02-03 | 40,000 | — | $0 | 40,000 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | A Award | 2017-02-01 | 2017-02-03 | 23,200 | — | $0 | 575,905 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2017-01-03 | 2017-01-05 | 2,802 | $103.92 | $291.2K | 552,705 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2016-12-06 | 2016-12-08 | 1,082 | — | $0 | 0 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2016-12-06 | 2016-12-08 | 2,405 | — | $0 | 1,354 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2016-12-06 | 2016-12-08 | 1,082 | $21.50 | $23.3K | 553,102 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2016-12-06 | 2016-12-08 | 2,405 | $31.90 | $76.7K | 555,507 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2016-10-03 | 2016-10-05 | 705 | $163.20 | $115.1K | 552,020 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2016-09-20 | 2016-09-22 | 8,411 | — | $0 | 0 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2016-09-20 | 2016-09-22 | 26,589 | — | $0 | 90,039 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2016-09-20 | 2016-09-22 | 8,411 | $9.82 | $82.6K | 587,725 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2016-09-20 | 2016-09-22 | 26,589 | $8.67 | $230.5K | 579,314 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2016-09-20 | 2016-09-22 | 35,000 | $165.00 | $5.78M | 552,725 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2016-07-15 | 2016-07-19 | 12,500 | — | $0 | 0 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | F Tax w/h | 2016-07-15 | 2016-07-19 | 7,341 | $148.73 | $1.09M | 552,725 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2016-07-15 | 2016-07-19 | 12,500 | $9.82 | $122.8K | 560,066 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2016-07-05 | 2016-07-07 | 714 | $145.11 | $103.6K | 547,566 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2016-04-04 | 2016-04-06 | 708 | $130.76 | $92.6K | 548,248 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | A Award deriv | 2016-02-10 | 2016-02-12 | 30,500 | — | $0 | 30,500 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | A Award | 2016-02-10 | 2016-02-12 | 23,300 | — | $0 | 552,856 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2016-01-04 | 2016-01-05 | 125 | $145.90 | $18.2K | 529,556 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2016-01-04 | 2016-01-05 | 2,001 | $145.90 | $291.9K | 529,681 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2016-01-01 | 2016-01-05 | 4,868 | — | $0 | 0 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2016-01-01 | 2016-01-05 | 4,868 | — | $0 | 531,682 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-10-02 | 2015-10-05 | 167 | $159.04 | $26.6K | 526,814 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | A Award deriv | 2015-10-01 | 2015-10-05 | 32,550 | — | $0 | 32,550 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2015-10-01 | 2015-10-05 | 4,867 | — | $0 | 4,868 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2015-10-01 | 2015-10-05 | 4,867 | — | $0 | 526,981 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | A Award | 2015-10-01 | 2015-10-05 | 15,100 | — | $0 | 522,114 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2015-07-10 | 2015-07-14 | 12,500 | — | $0 | 116,628 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-07-10 | 2015-07-14 | 12,500 | $250.00 | $3.13M | 507,014 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2015-07-10 | 2015-07-14 | 12,500 | $8.67 | $108.4K | 519,514 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-07-02 | 2015-07-07 | 2 | $239.00 | $478 | 507,014 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-07-02 | 2015-07-07 | 7 | $238.16 | $1.7K | 507,016 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-07-02 | 2015-07-07 | 149 | $236.13 | $35.2K | 507,023 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2015-07-01 | 2015-07-07 | 4,868 | — | $0 | 9,735 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2015-07-01 | 2015-07-07 | 4,868 | — | $0 | 507,172 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2015-06-03 | 2015-06-05 | 4,651 | — | $0 | 47,240 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2015-06-03 | 2015-06-05 | 1,910 | — | $0 | 34,404 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2015-06-03 | 2015-06-05 | 4,651 | $21.50 | $100.0K | 502,304 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2015-06-03 | 2015-06-05 | 1,910 | $8.67 | $16.6K | 497,653 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2015-05-14 | 2015-05-18 | 5,000 | — | $0 | 129,128 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-05-14 | 2015-05-18 | 5,000 | $300.00 | $1.50M | 495,743 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2015-05-14 | 2015-05-18 | 5,000 | $8.67 | $43.4K | 500,743 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2015-05-01 | 2015-05-05 | 12,500 | — | $0 | 134,128 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-05-01 | 2015-05-05 | 200 | $256.42 | $51.3K | 496,455 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2015-05-01 | 2015-05-05 | 12,500 | $8.67 | $108.4K | 508,243 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-05-01 | 2015-05-05 | 312 | $259.33 | $80.9K | 495,743 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-05-01 | 2015-05-05 | 400 | $258.50 | $103.4K | 496,055 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-05-01 | 2015-05-05 | 1,700 | $251.39 | $427.4K | 506,543 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-05-01 | 2015-05-05 | 661 | $255.49 | $168.9K | 496,655 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-05-01 | 2015-05-05 | 1,539 | $254.63 | $391.9K | 497,316 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-05-01 | 2015-05-05 | 4,338 | $253.52 | $1.10M | 498,855 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-05-01 | 2015-05-05 | 3,350 | $252.53 | $846.0K | 503,193 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-04-02 | 2015-04-03 | 157 | $277.70 | $43.6K | 495,743 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2015-04-01 | 2015-04-03 | 4,868 | — | $0 | 14,603 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2015-04-01 | 2015-04-03 | 4,868 | — | $0 | 495,900 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-01-05 | 2015-01-07 | 461 | $176.49 | $81.4K | 491,032 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2015-01-01 | 2015-01-05 | 4,868 | — | $0 | 19,471 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2015-01-01 | 2015-01-05 | 4,868 | — | $0 | 491,493 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2014-11-19 | 2014-11-20 | 31 | — | $0 | 51,891 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2014-11-19 | 2014-11-20 | 6,685 | — | $0 | 36,314 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2014-11-19 | 2014-11-20 | 31 | $21.50 | $667 | 486,625 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2014-11-19 | 2014-11-20 | 6,685 | $8.67 | $58.0K | 486,594 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2014-11-03 | 2014-11-05 | 10,000 | — | $0 | 146,628 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-11-03 | 2014-11-05 | 384 | $250.80 | $96.3K | 489,325 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-11-03 | 2014-11-05 | 3,166 | $260.68 | $825.3K | 483,359 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-11-03 | 2014-11-05 | 500 | $262.46 | $131.2K | 479,909 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2014-11-03 | 2014-11-05 | 10,000 | $8.67 | $86.7K | 489,909 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-11-03 | 2014-11-05 | 100 | $247.66 | $24.8K | 489,809 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-11-03 | 2014-11-05 | 100 | $249.69 | $25.0K | 489,709 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-11-03 | 2014-11-05 | 2,950 | $261.71 | $772.0K | 480,409 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-11-03 | 2014-11-05 | 300 | $252.90 | $75.9K | 489,025 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-11-03 | 2014-11-05 | 500 | $254.29 | $127.1K | 488,525 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-11-03 | 2014-11-05 | 300 | $255.30 | $76.6K | 488,225 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-11-03 | 2014-11-05 | 200 | $256.54 | $51.3K | 488,025 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-11-03 | 2014-11-05 | 400 | $257.96 | $103.2K | 487,625 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-11-03 | 2014-11-05 | 1,100 | $259.47 | $285.4K | 486,525 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2014-10-01 | 2014-10-03 | 10,000 | — | $0 | 156,628 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2014-10-01 | 2014-10-03 | 4,867 | — | $0 | 24,339 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-10-01 | 2014-10-03 | 1,400 | $226.53 | $317.1K | 488,509 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-10-01 | 2014-10-03 | 100 | $233.74 | $23.4K | 480,109 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-10-01 | 2014-10-03 | 200 | $234.94 | $47.0K | 479,909 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2014-10-01 | 2014-10-03 | 4,867 | — | $0 | 479,909 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2014-10-01 | 2014-10-03 | 10,000 | $8.67 | $86.7K | 489,909 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-10-01 | 2014-10-03 | 300 | $232.15 | $69.6K | 480,209 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-10-01 | 2014-10-03 | 1,450 | $227.64 | $330.1K | 487,059 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-10-01 | 2014-10-03 | 3,500 | $228.45 | $799.6K | 483,559 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-10-01 | 2014-10-03 | 1,750 | $229.30 | $401.3K | 481,809 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-10-01 | 2014-10-03 | 600 | $230.30 | $138.2K | 481,209 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-10-01 | 2014-10-03 | 700 | $231.31 | $161.9K | 480,509 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2014-09-02 | 2014-09-04 | 10,000 | — | $0 | 166,628 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-09-02 | 2014-09-04 | 1,600 | $287.48 | $460.0K | 476,042 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-09-02 | 2014-09-04 | 3,800 | $286.42 | $1.09M | 477,642 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-09-02 | 2014-09-04 | 3,600 | $285.56 | $1.03M | 481,442 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2014-09-02 | 2014-09-04 | 10,000 | $8.67 | $86.7K | 485,042 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-09-02 | 2014-09-04 | 200 | $289.72 | $57.9K | 475,042 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-09-02 | 2014-09-04 | 800 | $288.17 | $230.5K | 475,242 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2014-08-01 | 2014-08-06 | 10,000 | — | $0 | 176,628 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2014-08-01 | 2014-08-06 | 10,000 | $8.67 | $86.7K | 485,042 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-08-01 | 2014-08-06 | 10,000 | $226.72 | $2.27M | 475,042 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2014-07-01 | 2014-07-03 | 10,000 | — | $0 | 186,628 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2014-07-01 | 2014-07-03 | 4,868 | — | $0 | 29,206 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-07-01 | 2014-07-03 | 10,000 | $250.61 | $2.51M | 475,042 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2014-07-01 | 2014-07-03 | 4,868 | — | $0 | 475,042 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2014-07-01 | 2014-07-03 | 10,000 | $8.67 | $86.7K | 485,042 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2014-06-02 | 2014-06-04 | 10,000 | — | $0 | 196,628 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2014-06-02 | 2014-06-04 | 10,000 | $8.67 | $86.7K | 480,174 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-06-02 | 2014-06-04 | 10,000 | $230.60 | $2.31M | 470,174 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2014-05-01 | 2014-05-02 | 10,000 | — | $0 | 206,628 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2014-05-01 | 2014-05-02 | 10,000 | $8.67 | $86.7K | 480,174 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-05-01 | 2014-05-02 | 10,000 | $263.17 | $2.63M | 470,174 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2014-04-16 | 2014-04-17 | 10,000 | — | $0 | 216,628 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2014-04-16 | 2014-04-17 | 10,000 | $8.67 | $86.7K | 480,174 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-04-16 | 2014-04-17 | 10,000 | $242.22 | $2.42M | 470,174 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2014-04-15 | 2014-04-17 | 14,332 | — | $0 | 226,628 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2014-04-15 | 2014-04-17 | 2,866 | — | $0 | 42,999 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2014-04-15 | 2014-04-17 | 13,111 | — | $0 | 0 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2014-04-15 | 2014-04-17 | 13,111 | $2.89 | $37.9K | 452,976 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2014-04-15 | 2014-04-17 | 14,332 | $8.67 | $124.3K | 467,308 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2014-04-15 | 2014-04-17 | 2,866 | $8.67 | $24.8K | 470,174 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | A Award deriv | 2014-04-11 | 2014-04-15 | 5,733 | — | $0 | 5,733 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | A Award deriv | 2014-04-11 | 2014-04-15 | 22,931 | — | $0 | 22,931 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | A Award | 2014-04-11 | 2014-04-15 | 4,699 | — | $0 | 439,865 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2014-04-01 | 2014-04-03 | 4,868 | — | $0 | 34,074 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2014-04-01 | 2014-04-03 | 4,868 | — | $0 | 435,166 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2014-01-16 | 2014-01-17 | 10,000 | — | $0 | 240,960 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2014-01-16 | 2014-01-17 | 10,000 | $8.67 | $86.7K | 440,298 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-01-16 | 2014-01-17 | 10,000 | $273.68 | $2.74M | 430,298 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2014-01-01 | 2014-01-03 | 4,868 | — | $0 | 38,942 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2014-01-01 | 2014-01-03 | 4,868 | — | $0 | 416,635 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2013-12-30 | 2014-01-17 | 8,653 | — | $0 | 0 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2013-12-30 | 2014-01-17 | 12,850 | — | $0 | 13,111 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2013-12-30 | 2014-01-17 | 12,850 | $2.89 | $37.1K | 438,138 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2013-12-30 | 2014-01-17 | 8,653 | $2.89 | $25.0K | 425,288 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | G Gift | 2013-12-26 | 2014-01-17 | 7,840 | — | $0 | 430,298 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2013-10-01 | 2013-10-03 | 4,867 | — | $0 | 43,810 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2013-10-01 | 2013-10-03 | 4,867 | — | $0 | 406,899 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2013-09-17 | 2013-09-18 | 12,500 | — | $0 | 0 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2013-09-17 | 2013-09-18 | 12,500 | — | $0 | 20,911 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2013-09-17 | 2013-09-18 | 12,500 | $9.82 | $122.8K | 414,532 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2013-09-17 | 2013-09-18 | 12,500 | $9.82 | $122.8K | 427,032 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2013-09-17 | 2013-09-18 | 25,000 | $52.00 | $1.30M | 402,032 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2013-09-13 | 2013-09-13 | 3,906 | — | $0 | 12,500 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2013-09-13 | 2013-09-13 | 7,694 | — | $0 | 33,411 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2013-09-13 | 2013-09-13 | 1,796 | $48.51 | $87.1K | 411,836 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2013-09-13 | 2013-09-13 | 9,804 | $49.05 | $480.9K | 402,032 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2013-09-13 | 2013-09-13 | 7,694 | $9.82 | $75.6K | 413,632 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2013-09-13 | 2013-09-13 | 3,906 | $9.82 | $38.4K | 405,938 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2013-09-12 | 2013-09-13 | 900 | — | $0 | 16,406 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2013-09-12 | 2013-09-13 | 900 | $9.82 | $8.8K | 402,932 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2013-09-12 | 2013-09-13 | 900 | $49.65 | $44.7K | 402,032 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2013-08-12 | 2013-08-13 | 12,500 | — | $0 | 17,306 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2013-08-12 | 2013-08-13 | 12,500 | $9.82 | $122.8K | 414,532 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2013-08-12 | 2013-08-13 | 12,500 | $45.98 | $574.8K | 402,032 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2013-07-15 | 2013-07-16 | 21,700 | — | $0 | 29,806 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2013-07-15 | 2013-07-16 | 1,659 | $50.64 | $84.0K | 402,032 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2013-07-15 | 2013-07-16 | 20,041 | $49.78 | $997.6K | 403,691 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2013-07-15 | 2013-07-16 | 21,700 | $9.82 | $213.1K | 423,732 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2013-07-12 | 2013-07-16 | 3,300 | — | $0 | 51,506 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2013-07-12 | 2013-07-16 | 3,300 | $9.82 | $32.4K | 405,332 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2013-07-12 | 2013-07-16 | 2,000 | $51.04 | $102.1K | 403,332 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2013-07-12 | 2013-07-16 | 1,300 | $51.83 | $67.4K | 402,032 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2013-07-09 | 2013-07-10 | 2,403 | — | $0 | 0 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2013-07-09 | 2013-07-10 | 10,097 | — | $0 | 54,806 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2013-07-09 | 2013-07-10 | 10,097 | $9.82 | $99.2K | 414,532 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2013-07-09 | 2013-07-10 | 12,500 | $48.26 | $603.3K | 402,032 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2013-07-09 | 2013-07-10 | 2,403 | $9.82 | $23.6K | 404,435 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2013-07-08 | 2013-07-10 | 25,000 | — | $0 | 2,403 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2013-07-08 | 2013-07-10 | 25,000 | $45.41 | $1.14M | 402,032 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2013-07-08 | 2013-07-10 | 25,000 | $9.82 | $245.5K | 427,032 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2013-07-01 | 2013-07-03 | 4,868 | — | $0 | 48,677 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2013-07-01 | 2013-07-03 | 4,868 | — | $0 | 406,900 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2013-06-26 | 2013-06-27 | 12,300 | — | $0 | 27,403 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2013-06-26 | 2013-06-27 | 12,300 | $40.06 | $492.7K | 402,032 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2013-06-26 | 2013-06-27 | 12,300 | $9.82 | $120.8K | 414,332 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2013-06-25 | 2013-06-27 | 200 | — | $0 | 39,703 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2013-06-25 | 2013-06-27 | 200 | $40.00 | $8.0K | 402,032 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2013-06-25 | 2013-06-27 | 200 | $9.82 | $2.0K | 402,232 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2013-06-20 | 2013-06-21 | 16,000 | — | $0 | 39,903 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2013-06-20 | 2013-06-21 | 16,000 | $9.82 | $157.1K | 418,032 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2013-06-20 | 2013-06-21 | 16,000 | $38.35 | $613.6K | 402,032 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2013-06-19 | 2013-06-21 | 9,000 | — | $0 | 55,903 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2013-06-19 | 2013-06-21 | 9,000 | $9.82 | $88.4K | 411,032 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2013-06-19 | 2013-06-21 | 9,000 | $38.08 | $342.7K | 402,032 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | A Award deriv | 2013-05-07 | 2013-05-09 | 65,000 | — | $0 | 65,000 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | A Award | 2013-05-07 | 2013-05-09 | 7,700 | — | $0 | 402,032 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2013-04-09 | 2013-04-11 | 24,339 | — | $0 | 53,545 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | F Tax w/h | 2013-04-09 | 2013-04-11 | 10,774 | $34.57 | $372.5K | 394,332 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2013-04-09 | 2013-04-11 | 24,339 | — | $0 | 405,106 | SEC↗ |